From: Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report
Agent
Purpura (number of patients)
Renal toxicity (number of patients)
Purpura and renal toxicity (number of patients)
Panitumumab
2
1
Cetuximab
Gefitinib
5
4
0
Erlotinib
3